のれん償却額 - 医薬品開発支援、契約負債、法人税等合計他2件
- 【期間】
| 年度 | のれん償却額 - 医薬品開発支援 | 契約負債 | 法人税等合計 | 未収入金 | 繰延税金資産 |
|---|
| 2008/03 | - | | - | | 14.7億 | | 0.18億 | | 7.28億 | |
| 2009/03 | - | | - | | 14.7億 | +0.1% | 0.31億 | +75.3% | 7.31億 | +0.5% |
| 2010/03 | - | | - | | 13.9億 | -5.5% | 0.37億 | +18% | 8.23億 | +12.6% |
| 2011/03 | - | | - | | 15.3億 | +10.1% | 0.43億 | +16.7% | 9.72億 | +18% |
| 2012/03 | - | | - | | 15.1億 | -1.2% | 0.33億 | -23.6% | 9.44億 | -2.9% |
| 2013/03 | 75百万 | | - | | 13.5億 | -10.8% | 0.55億 | +67.4% | 11.6億 | +23.1% |
| 2014/03 | 73百万 | -1.6% | - | | 17億 | +25.8% | 3.16億 | +471.2% | 11.3億 | -2.5% |
| 2015/03 | 12百万 | -83.3% | - | | 26.1億 | +53.5% | 5.34億 | +69.2% | 11億 | -2.7% |
| 2016/03 | - | | - | | 14.9億 | -43% | 3.14億 | -41.3% | 11億 | +0.1% |
| 2017/03 | - | | - | | 13.9億 | -6.5% | 10.2億 | +225.5% | 11.9億 | +7.7% |
| 2018/03 | - | | - | | 12.9億 | -6.8% | 7.34億 | -28.1% | 12.2億 | +2.5% |
| 2019/03 | - | | - | | 14.2億 | +9.5% | 8.81億 | +19.9% | - | |
| 2020/06 | - | | - | | 12.9億 | -8.9% | 5.69億 | -35.3% | - | |
| 2021/06 | - | | - | | 17.5億 | +35.8% | 11.7億 | +105.6% | - | |
| 2022/06 | - | | 923百万 | | 16.5億 | -6.1% | 11億 | -5.7% | - | |
| 2023/06 | - | | 750百万 | -18.8% | 8.85億 | -46.2% | 6.72億 | -39.2% | - | |
